semaglutide cardiovascular outcomes news 2025 october currently not cost-effective for heart patients without diabetes, study finds Semaglutide 2.4 mg delivered a

It's f***ing awesome."FilmMagic

Baetu, Irina, et al

Weight Loss Advantage: Clinical data show robust weight loss outcomes, aligning with Richards goal of achieving a healthier BMI (17)

Bleeding Risks One of the primary concerns when combining warfarin with other medications is the increased risk of bleeding

Results: What Adults Over 50 Can Realistically Expect Clinical trial data on GLP-1 medications generally skews toward younger to middle-aged adult populations, but real-world evidence and subgroup analyses suggest that adults over 50 achieve meaningful weight loss on these medications, though often at a somewhat slower pace than younger patients